Efficacy of short hydration for intermediate to high-dose cisplatin-based chemotherapy for outpatients: shortcis trial process: submission:07/28/2021 acceptance:10/02/2022 efficacy of short hydration for intermediate to high-dose cisplatin-based chemotherapy for outpatients: shortcis trial

HIGHLIGHTS

• who: Asian Pac J Cancer et al. from the (UNIVERSITY) have published the article: Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial Process: Submission:07/28/2021 Acceptance:10/02/2022 Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial, in the Journal: (JOURNAL)

SUMMARY

Cisplatin is a chemotherapy drug formulated for treating different types of cancer, e_g lung cancer, gastric cancer, esophageal cancer, head and neck cancer (Bunn, 1989; Aisner and Abrams, 1989; Szturz et_al, 2019; Iocca . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.